Designer Collagen Fibers for Tissue Engineering Applications
- Summary
- Purdue University researchers have incorporated metal binding sites into small collagen peptides and used metal-ligand interactions to drive aggregation. Self-assembly of 3D structures is spontaneous, highly reproducible, and reversible. Fine, nanoscale detail and ultimate control at the single molecular level give rise to tunable shapes, sizes, and tertiary structures. Physical properties, such as mechanical strength, tensile strength, and porosity, may be modified in a predetermined way, as the physical properties of collagen play a central role in cell growth and differentiation. Reversibility of collagen aggregates, whereby aggregates are converted back to smaller subunits, may be advantageous for controlled release of drugs, cells, growth factors, etc. With aggregate structures so diverse, including spheres, nanospheres, hollow spheres, meshes, cages, microflorettes, fibers, and sheets, these designer synthetic collagen aggregates find applications across the spectrum.
- Technology Benefits
- Control of 3D structure of collagen networksExcellent biocompatibility and bioactivity
- Technology Application
- BiotechnologyMaterials
- Detailed Technology Description
- Jean ChmielewskiChmielewski Research GroupPurdue Biomedical Engineering
- Countries
- United States
- Application No.
- 8,575,311
- *Abstract
-
- *Background
- Collagen holds organs in place, binds cells together, confers appropriate mechanical properties for tissues, and provides a framework for the body. The ubiquitous influence of collagen makes it an attractive target for implantable and regenerative tissue systems; however, the use of natural collagen in tissue engineering applications is limited due to difficulty with precise control of scaffold structures. Furthermore, natural collagen aggregates are inherently inconsistent, complicating precise introduction of biomolecules such as growth factors and cell adhesion agents. Synthetic collagen alleviates these problems, but there is still a need to control the 3D architecture of collagen networks.
- *IP Issue Date
- Nov 5, 2013
- *IP Type
- Utility
- *Stage of Development
- Proof of Concept
- *Web Links
- Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipJean ChmielewskiChmielewski Research GroupPurdue Biomedical Engineering
- Country/Region
- USA
For more information, please click Here
